✦ LIBER ✦

Comparative tolerance of IFN beta-1a regimens in patients with relapsing multiple sclerosis

✍ Scribed by M. Sandberg-Wollheim; C. Bever; J. Carter; M. Färkkilä; B. Hurwitz; Y. Lapierre; P. Chang; G. S. Francis

Publisher: Springer
Year: 2005
Tongue: English
Weight: 304 KB
Volume: 252
Category: Article
ISSN: 0340-5354
DOI: 10.1007/s00415-005-0589-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Management of neutralizing antibodies ag

Management of neutralizing antibodies against beta-IFN in beta-IFN-treated multiple sclerosis patients

✍ Andrew R. Pachner; Jennifer Brady; Israel Steiner; Kavitha Narayan 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 124 KB

fMRI changes in relapsing-remitting mult

fMRI changes in relapsing-remitting multiple sclerosis patients complaining of fatigue after IFNβ-1a injection

✍ Maria A. Rocca; Federica Agosta; Bruno Colombo; Domenico M. Mezzapesa; Andrea Fa 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 228 KB

## Abstract If fatigue in multiple sclerosis (MS) is related to an abnormal activation of the sensorimotor brain network, the activity of such a network should vary with varying fatigue. We studied 22 patients treated with interferon beta 1a (IFNβ‐1a; Avonex, Biogen, Cambridge, MA) with no fatigue

Serum gelatinase B/MMP-9 in primary prog

Serum gelatinase B/MMP-9 in primary progressive multiple sclerosis patients treated with interferon-beta-1a

✍ Bénédicte Dubois; SiobhanM. Leary; Inge Nelissen; Ghislain Opdenakker; Gavin Gio 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 281 KB

Predictive factors of neutralizing antib

Predictive factors of neutralizing antibodies development in relapsing-remitting multiple sclerosis patients on interferon Beta-1b therapy

✍ R. Lanzillo; G. Orefice; A. Prinster; G. Ventrella; R. Liuzzi; V. Scarano; C. Fl 📂 Article 📅 2011 🏛 Springer Milan 🌐 English ⚖ 174 KB

Recurrent nephrotic syndrome in patient

Recurrent nephrotic syndrome in patient with multiple sclerosis treated with interferon beta-1a

✍ Maria Rosaria Tola; Luisa Maria Caniatti; Daniela Gragnaniello; Monia Russo; Nev 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 115 KB

Efficacy and tolerability of natalizumab

Efficacy and tolerability of natalizumab in relapsing–remitting multiple sclerosis patients: a post-marketing observational study

✍ F. Sangalli; L. Moiola; S. Bucello; P. Annovazzi; A. Rizzo; M. Radaelli; G. Vite 📂 Article 📅 2010 🏛 Springer Milan 🌐 English ⚖ 238 KB